Opioid Addiction

19 registered clinical trials studyying Opioid Addiction.

Status	Trial	Sponsor	Phase
Active Not Recruiting	MEDiterranean Diet-driven Detoxification of OPioid Addicted patiEnts (MED-DOPE) NCT07022782	Aristidis Veskoukis	N/A
Terminated	Duloxetine Impact on Postoperative Pain Control and Outcomes NCT05611749	Scripps Health	Phase 2
Completed	Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence NCT05299515	University of Maryland, College Park	N/A
Completed	sTMS for Substance Use-disordered Veterans NCT04336293	VA Office of Research and Development	N/A
Active Not Recruiting	Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support NCT04309565	Yale University	N/A
Active Not Recruiting	Integrating Support Persons Into Recovery NCT04239235	Stanford University	N/A
Unknown	Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction NCT03394911	Bubba Nicholson	Phase 3
Completed	An Innovative Intervention for OUD Treatment NCT04325659	Johns Hopkins University	Phase 2 / Phase 3
Completed	Observational Study to Evaluate Levomethadone Safety and Effectiveness in Subjects Under Opioid Maintenance Tr NCT03685162	L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.	—
Unknown	PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction NCT02282072	Beijing Pins Medical Co., Ltd	EARLY_Phase 1
Completed	Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence NCT02696096	Butler Hospital	Phase 3
Completed	Testosterone Replacement for Male Opioid Agonist Maintained Patients NCT01873989	Yale University	Phase 1 / Phase 2
Completed	Yoga for Pain and Opioid Dependence NCT01590251	Yale University	Phase 1 / Phase 2
Completed	Medications Development for Drug Abuse Disorders NCT01188421	Johns Hopkins University	Phase 1 / Phase 2
Unknown	Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation. NCT01008072	Assaf-Harofeh Medical Center	—
Completed	The Discriminative Effects of Tramadol in Humans NCT00499746	National Institute on Drug Abuse (NIDA)	Phase 1 / Phase 2
Unknown	ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning NCT02866266	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases NCT02897414	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers NCT02871232	ER/LA Opioid REMS Program Companies (RPC)	—